266 related articles for article (PubMed ID: 32158052)
1. Medications for Opioid Use Disorder: A Guide for Physicians.
Azhar N; Chockalingam R; Azhar A
Mo Med; 2020; 117(1):59-64. PubMed ID: 32158052
[TBL] [Abstract][Full Text] [Related]
2. Opioid Use Disorder: Medical Treatment Options.
Coffa D; Snyder H
Am Fam Physician; 2019 Oct; 100(7):416-425. PubMed ID: 31573166
[TBL] [Abstract][Full Text] [Related]
3. Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality.
Kelty E; Hulse G; Joyce D; Preen DB
CNS Drugs; 2020 Jun; 34(6):629-642. PubMed ID: 32215842
[TBL] [Abstract][Full Text] [Related]
4. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
[No Abstract] [Full Text] [Related]
5. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.
Morgan JR; Schackman BR; Weinstein ZM; Walley AY; Linas BP
Drug Alcohol Depend; 2019 Jul; 200():34-39. PubMed ID: 31082666
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine implants in medical treatment of opioid addiction.
Chavoustie S; Frost M; Snyder O; Owen J; Darwish M; Dammerman R; Sanjurjo V
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):799-807. PubMed ID: 28571505
[TBL] [Abstract][Full Text] [Related]
7. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
Cottrill CB; Matson SC
Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
[No Abstract] [Full Text] [Related]
8. Medications for management of opioid use disorder.
Koehl JL; Zimmerman DE; Bridgeman PJ
Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive memantine for opioid use disorder treatment: A systematic review.
Elias AM; Pepin MJ; Brown JN
J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
[TBL] [Abstract][Full Text] [Related]
10. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
Soyka M; Kranzler HR; van den Brink W; Krystal J; Möller HJ; Kasper S;
World J Biol Psychiatry; 2011 Apr; 12(3):160-87. PubMed ID: 21486104
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine implants (Probuphine) for opioid dependence.
Med Lett Drugs Ther; 2016 Jul; 58(1499):94-5. PubMed ID: 27403784
[No Abstract] [Full Text] [Related]
12. Opioid dependence.
Praveen KT; Law F; O'Shea J; Melichar J
Am Fam Physician; 2012 Sep; 86(6):565-6. PubMed ID: 23062049
[No Abstract] [Full Text] [Related]
13. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
Pan A; Zakowski M
Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
[TBL] [Abstract][Full Text] [Related]
14. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine Treatment for Opioid Use Disorder: An Overview.
Shulman M; Wai JM; Nunes EV
CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259
[TBL] [Abstract][Full Text] [Related]
16. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.
Terasaki D; Smith C; Calcaterra SL
Pharmacotherapy; 2019 Oct; 39(10):1023-1029. PubMed ID: 31348544
[TBL] [Abstract][Full Text] [Related]
17. Update on pharmacotherapy for treatment of opioid use disorder.
Ayanga D; Shorter D; Kosten TR
Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
[TBL] [Abstract][Full Text] [Related]
18. Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.
Med Lett Drugs Ther; 2018 Feb; 60(1541):35-37. PubMed ID: 29485976
[No Abstract] [Full Text] [Related]
19. Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.
Clark N; Verster A
Addiction; 2013 Feb; 108(2):253-5. PubMed ID: 23331880
[No Abstract] [Full Text] [Related]
20. Developing an opioid use disorder treatment cascade: A review of quality measures.
Williams AR; Nunes EV; Bisaga A; Pincus HA; Johnson KA; Campbell AN; Remien RH; Crystal S; Friedmann PD; Levin FR; Olfson M
J Subst Abuse Treat; 2018 Aug; 91():57-68. PubMed ID: 29910015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
